Increasing evidence suggests that large intervening non-coding RNAs (lincRNAs) regulate key pathways in cancer invasion and metastasis. In this observational retrospective study, the expression of the oncogenic lincRNA HOX transcript antisense RNA (HOTAIR) gene was measured in 63 patients with hepatocellular carcinoma (HCC) following hepatic resection. The HOTAIR gene was significantly overexpressed in HCC tissues compared with adjacent non-tumour tissues. Patients with high HOTAIR gene expression in their tumours had an increased risk of recurrence after hepatectomy. There was also a significant correlation between HOTAIR expression and lymph node metastasis. In vitro assays in the HCC cell line Bel7402 demonstrated that knockdown of HOTAIR lincRNA reduced cell proliferation and was associated with reductions in levels of matrix metalloproteinase-9 and vascular endothelial growth factor protein, which are important for cell motility and metastasis. In conclusion, HOTAIR lincRNA might be a potential biomarker for the existence of lymph node metastasis in HCC.
ParkinDMBrayFFerlayJ: Estimating the world cancer burden: Globocan 2000. Int J Cancer2001; 94: 153–156.
2.
JemalABrayFCenterMM: Global cancer statistics. CA Cancer J Clin2011; 61: 69–90.
3.
El-SeragHBMasonAC: Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med1999; 340: 745–750.
4.
Taylor-RobinsonSDFosterGRAroraS: Increase in primary liver cancer in the UK, 1979–94. Lancet1997; 350: 1142–1143.
5.
JemalASiegelRXuJ: Cancer statistics, 2010. CA Cancer J Clin2010; 60: 277–300.
6.
TangZY: Hepatocellular carcinoma surgery: review of the past and prospects for the 21st century. J Surg Oncol2005; 91: 95–96.
7.
HaoKLukJMLeeNP: Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters. BMC Cancer2009; 9: 389.
8.
BertonePStolcVRoyceTE: Global identification of human transcribed sequences with genome tiling arrays. Science2004; 306: 2242–2246.
9.
AmaralPPDingerMEMercerTR: The eukaryotic genome as an RNA machine. Science2008; 319: 1787–1789.
10.
GuttmanMAmitIGarberM: Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature2009; 458: 223–227.
11.
FengJBiCClarkBS: The Evf-2 noncoding RNA is transcribed from the Dlx-5/6 ultraconserved region and functions as a Dlx-2 transcriptional coactivator. Genes Dev2006; 20: 1470–1484.
12.
WangXAraiSSongX: Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature2008; 454: 126–130.
13.
SunwooHDingerMEWiluszJE: MEN e/β nuclear-retained non-coding RNAs are up-regulated upon muscle differentiation and are essential components of paraspeckles. Genome Res2009; 19: 347–359.
14.
YuWGiusDOnyangoP: Epigenetic silencing of tumour suppressor gene p15 by its antisense RNA. Nature2008; 451: 202–206.
15.
SongXWangBBrombergM: Retroviral-mediated transmission of a mouse VL30 RNA to human melanoma cells promotes metastasis in an immunodeficient mouse model. Proc Natl Acad Sci U S A2002; 99: 6269–6273.
16.
WangFLiXXieX: UCA1, a non-protein-coding RNA up-regulated in bladder carcinoma and embryo, influencing cell growth and promoting invasion. FEBS Lett2008; 582: 1919–1927.
17.
RinnJLKerteszMWangJK: Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell2007; 129: 1311–1323.
18.
TsaiMCManorOWanY: Long noncoding RNA as modular scaffold of histone modification complexes. Science2010; 329: 689–693.
19.
GuptaRAShahNWangKC: Long noncoding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature2010; 464: 1071–1076.
20.
WanYChangHY: HOTAIR: flight of noncoding RNAs in cancer metastasis. Cell Cycle2010; 9: 3391–3392.
21.
LivakKJSchmittgenTD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods2001; 25: 402–408.
22.
HuarteMRinnJL: Large non-coding RNAs: missing links in cancer?Hum Mol Genet2010; 19: R152–R161.
23.
JiPDiederichsSWangW: MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene2003; 22: 8031–8041.
24.
YangZZhouLWuLM: Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation. Ann Surg Oncol2011; 18: 1243–1250.
25.
XiaohongSHuikaiLFengW: Clinical significance of lymph node metastasis in patients undergoing partial hepatectomy for hepatocellular carcinoma. World J Surg2010; 34: 1028–1033.
26.
SunHCZhuangPYQinLX: Incidence and prognostic values of lymph node metastasis in operable hepatocellular carcinoma and evaluation of routine complete lymphadenectomy. J Surg Oncol2007; 96: 37–45.
27.
UenishiTHirohashiKShutoT: The clinical significance of lymph node metastases in patients undergoing surgery for hepatocellular carcinoma. Surg Today2000; 30: 892–895.
28.
YaoFYFerrellLBassNM: Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl2002; 8: 765–774.
29.
DelisSGBakoyiannisATassopoulosN: Hepatic resection for large hepatocellular carcinoma in the era of UCSF criteria. HPB (Oxford)2009; 11: 551–558.
30.
AlsinaAE: Liver transplantation for hepatocellular carcinoma. Cancer Control2010; 17: 83–86.
31.
KimKJLiBWinerJ: Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo. Nature1993; 362: 841–844.
32.
LiLZhangRFangZY: Suppression of vascular endothelial growth factor (VEGF) expression by targeting the Bcr-Abl oncogene and protein tyrosine kinase activity in Bcr-Abl-positive leukaemia cells. J Int Med Res2009; 37: 426–437.
33.
LeeLYWuCMWangCC: Expression of matrix metalloproteinases MMP-2 and MMP-9 in gastric cancer and their relation to claudin-4 expression. Histol Histopathol2008; 23: 515–521.
34.
MareshGAErezyilmazDMurryCE: Detection and quantitation of perlecan mRNA levels in Alzheimer's disease and normal aged hippocampus by competitive reverse transcription-polymerase chain reaction. J Neurochem1996; 67: 1132–1144.
35.
MilasMShinJGuptaM: Circulating thyrotropin receptor mRNA as a novel marker of thyroid cancer: clinical applications learned from 1758 samples. Ann Surg2010; 252: 643–651.
36.
Al OlabyRRAzzazyHM: Hepatitis C virus RNA assays: current and emerging technologies and their clinical applications. Expert Rev Mol Diagn2011; 11: 53–64.
37.
LuJGetzGMiskaEA: MicroRNA expression profiles classify human cancers. Nature2005; 435: 834–838.
38.
BishopJABenjaminHCholakhH: Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach. Clin Cancer Res2010; 16: 610–619.
